Siglec15 shapes a non-inflamed tumor microenvironment and predicts the molecular subtype in bladder cancer.
Hu J, Yu A, Othmane B, Qiu D, Li H, Li C, Liu P, Ren W, Chen M, Gong G, Guo X, Zhang H, Chen J, Zu X.
Theranostics. 2021 Jan 1;11(7):3089-3108. doi: 10.7150/thno.53649. eCollection 2021.
FGFR inhibition augments anti-PD-1 efficacy in murine FGFR3-mutant bladder cancer by abrogating immunosuppression.
Okato A, Utsumi T, Ranieri M, Zheng X, Zhou M, Pereira LD, Chen T, Kita Y, Wu D, Hyun H, Lee H, Gdowski AS, Raupp JD, Clark-Garvey S, Manocha U, Chafitz A, Sherman F, Stephens J, Rose TL, Milowsky MI, Wobker SE, Serody JS, Damrauer JS, Wong KK, Kim WY.
J Clin Invest. 2024 Jan 16;134(2):e169241. doi: 10.1172/JCI169241.
Intravesical bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: a randomised, placebo-controlled, double-blind clinical trial.
Leitner L, Ujmajuridze A, Chanishvili N, Goderdzishvili M, Chkonia I, Rigvava S, Chkhotua A, Changashvili G, McCallin S, Schneider MP, Liechti MD, Mehnert U, Bachmann LM, Sybesma W, Kessler TM.
Lancet Infect Dis. 2021 Mar;21(3):427-436. doi: 10.1016/S1473-3099(20)30330-3. Epub 2020 Sep 16.
Ultrasound versus Nerve Stimulator Guided Obturator Nerve Block in Patients Undergoing Transurethral Resection of Bladder Tumor.
Baral BK, Poudel PR, Rajbhandari M, Karki AJ, Dhakal GR.
J Nepal Health Res Counc. 2023 Jul 20;20(4):998-1002. doi: 10.33314/jnhrc.v20i4.4523.
Immune checkpoint inhibitors for urothelial carcinoma.
Kim HS, Seo HK.
Investig Clin Urol. 2018 Sep;59(5):285-296. doi: 10.4111/icu.2018.59.5.285. Epub 2018 Aug 31.
Placenta Previa Accreta Spectrum: Cesarean Hysterectomy.
Takeda S, Takeda J, Murayama Y.
Surg J (N Y). 2021 May 25;7(Suppl 1):S28-S37. doi: 10.1055/s-0040-1721492. eCollection 2021 Dec.
Outcome of transurethral resection of bladder tumour under spinal anaesthesia combined with obturator nerve block in Sri Lanka.
Ambegoda M, Shiyanth S, Vidanapathirana S, Kumara S, Gunaratne A, Abeygunasekera A.
Urologia. 2023 Feb;90(1):80-82. doi: 10.1177/03915603221127843. Epub 2022 Nov 3.
Mini-Review: Current Bladder Cancer Treatment-The Need for Improvement.
Gill E, Perks CM.
Int J Mol Sci. 2024 Jan 26;25(3):1557. doi: 10.3390/ijms25031557.
Radiation-induced cystitis treated with hyperbaric oxygen therapy (RICH-ART): a randomised, controlled, phase 2-3 trial.
Oscarsson N, Müller B, Rosén A, Lodding P, Mölne J, Giglio D, Hjelle KM, Vaagbø G, Hyldegaard O, Vangedal M, Salling L, Kjellberg A, Lind F, Ettala O, Arola O, Seeman-Lodding H.
Lancet Oncol. 2019 Nov;20(11):1602-1614. doi: 10.1016/S1470-2045(19)30494-2. Epub 2019 Sep 16.
Properties of FDA-approved small molecule protein kinase inhibitors: A 2020 update.
Roskoski R Jr.
Pharmacol Res. 2020 Feb;152:104609. doi: 10.1016/j.phrs.2019.104609. Epub 2019 Dec 17.
